We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Global Radiation Dose Management Market Driven by Rising Demand for Minimally Invasive Procedures

By MedImaging International staff writers
Posted on 26 Apr 2023
Print article
Image: The global radiation dose management market is anticipated to witness an impressive growth (Photo courtesy of Freepik)
Image: The global radiation dose management market is anticipated to witness an impressive growth (Photo courtesy of Freepik)

In the past two decades, there has been a significant increase in radiation exposure to patients due to the growing use of diagnostic tests like CT scans, fluoroscopy, and interventional imaging procedures. The global radiation dose management market is expected to experience impressive growth in the coming years, driven by factors such as the rising incidence of chronic diseases, increasing concerns over radiation dose exposure, growth in the installed base of radiology equipment, and heightened awareness of radiation dose management.

These are the latest findings of Research and Markets (Dublin, Ireland), a leading source for market research reports.

The robust growth of the global radiation dose management market can also be attributed to the increasing demand for patient safety, strict federal and state regulations, obligations for healthcare providers, and the expanding healthcare infrastructure in developing regions. Moreover, advancements in radiation devices and the growing adoption of radiation dose management by patients and healthcare providers will serve as key growth drivers for the market in the future.

Additionally, the rising prevalence of cancer is anticipated to fuel the growth of the global radiation dose management market. Cancer is the second leading cause of death worldwide and is growing rapidly due to factors such as alcohol consumption, excessive smoking, and unhealthy lifestyles. Interventional oncology devices are used for cancer diagnosis and treatment, as well as for assisting surgeons in developing appropriate treatment plans. The swift adoption of new technology can increase the demand for interventional oncology devices, driving the growth of the global radiation dose management market. The growing demand for minimally invasive surgeries is also expected to contribute significantly to market growth.

Regionally, North America dominates the global radiation dose management market, with the U.S. accounting for a major share of the North American market. This is due to the rising demand for minimally invasive surgeries and the low cost of chronic disease treatments, such as cancer, in the country.

Related Links:
Research and Markets

3T MRI Scanner
MAGNETOM Cima.X
New
Needle Guide Disposable Kit
Verza
Multi-Use Ultrasound Table
Clinton
New
Cylindrical Water Scanning System
SunSCAN 3D

Print article

Channels

Radiography

view channel
Image: AI can identify “mammographically-visible” types of interval cancers earlier by flagging them at the time of screening (Photo courtesy of ScreenPoint Medical)

AI Improves Early Detection of Interval Breast Cancers

Interval breast cancers, which occur between routine screenings, are easier to treat when detected earlier. Early detection can reduce the need for aggressive treatments and improve the chances of better outcomes.... Read more

MRI

view channel
Image: An MRI scan can reveal a heart’s functional age (Photo courtesy of 123RF)

New MRI Technique Reveals True Heart Age to Prevent Attacks and Strokes

Heart disease remains one of the leading causes of death worldwide. Individuals with conditions such as diabetes or obesity often experience accelerated aging of their hearts, sometimes by decades.... Read more

Nuclear Medicine

view channel
Image: In vivo imaging of U-87 MG xenograft model with varying mass doses of 89Zr-labeled KLG-3 or isotype control (Photo courtesy of L Gajecki et al.; doi.org/10.2967/jnumed.124.268762)

Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors

Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.